Paranovus Entertainment Technology Ltd

NAS:PAVSHealthcareNASDAQ:INDSnasdaq_composite

$2.80−5.18%LiveIn session · ≈ AED 10.27 · Market cap $2.43M · Next earnings Fri 15 Jan

USD millions	FY2020	FY2021	FY2022	FY2023	FY2024	FY2026	YoY
Net income	0.8	(49.2)	(4.1)	(4.5)	(6.6)	—	—
Depreciation & amortization	0.9	2.2	0.1	0.4	0.4	2.1	+444.7%
Stock-based compensation	0.0	0.0	0.0	0.0	0.0	—	—
Change in working capital	0.6	15.1	(0.5)	(1.1)	0.1	—	—
Operating cash flow	2.9	(28.1)	(3.0)	(13.1)	(2.7)	(1.4)	+47.6%
Capital expenditure	(2.8)	(2.4)	0.0	0.0	(0.0)	0.0	+100.0%
Acquisitions	(9.4)	(8.0)	0.0	0.0	(22.3)	—	—
Investing cash flow	(13.2)	(8.5)	0.1	11.7	(27.0)	—	—
Dividends paid	(0.4)	0.0	0.0	0.0	0.0	—	—
Share buybacks	0.0	0.0	0.0	0.0	0.0	—	—
Debt issued / repaid	0.0	(0.0)	0.0	0.0	0.2	—	—
Financing cash flow	10.6	18.8	3.1	0.0	29.0	—	—
Free cash flow	0.1	(30.5)	(3.0)	(13.1)	(2.7)	(1.4)	+47.6%
Net change in cash	2.9	(16.8)	(17.7)	(1.7)	(0.1)	—	—

USD millionsUpdated Fri 14 Aug ·

ⓘ

Amounts are shown in the stated units; per-share amounts and shares are unscaled. Negative amounts are in brackets.